^

ASTRO Blog

What Comes Next: Advocacy in 2021

By Casey Chollet, MD, Government Relations Committee Chair

2020. By any standard, it was a year to remember...and forget. The COVID-19 pandemic took hold over almost everyone’s energy and focus, sidelining so many routine things we previously took for granted. While the public health emergency rightly became the primary focus of our medical community, the radiation oncology field continued to face direct challenges and looming burdens on the congressional horizon. Be it the threat of a flawed RO Model, payment cuts in the 2021 Medicare Physician Fee Schedule (MPFS) or the progressive burdens of prior authorization, the ASTRO Advocacy team continued to fight for relief throughout the year.

Ultimately, 2020 closed with many victories for our community. The RO Model was delayed until at least January 2022, saving participants approximately $45 million in 2021. Payment cuts in the 2021 MPFS were significantly reduced, protecting radiation oncology from another $100 million in losses in 2021. And prior authorization reform legislation received the support of more than 280 bipartisan co-sponsors in the House, as well as a companion bill introduced in the Senate. On top of these radiation oncology victories, COVID-19 support was secured in the form of continued funding for the Provider Relief Fund that helped offset revenue declines triggered by the reduction of in-person care visits and cancer screenings.

These victories were possible only because of close collaboration between ASTRO Advocacy and our members, and strengthening this collaboration is critical to making 2021 even more successful for radiation oncology. Whether it be through participating in Advocacy Day or email advocacy campaigns, increased engagement by our membership is critical to success.

For instance, ASTRO staff lobbyists and Najeeb Mohideen, MD, FASTRO, teamed up to keep Rep. Raja Krishnamoorthi (D-IL), Dr. Mohideen’s congressman, informed about RO Model concerns. In response, Rep. Krishnamoorthi joined his colleagues in writing the HHS Secretary at the time, Alex Azar, about the need for reforms.

In 2020, ASTRO members sent over 3,200 messages to their representatives and senators advocating for our specialty: that’s almost nine messages a day! Rising to the challenge of the COVID era, 69 members participated in a virtual Advocacy Day on the Hill, attending over 90 meetings. But despite these impressive efforts, our specialty must do more to achieve our long-term policy goals. If we were able to make such a big impact in 2020 with a relatively small level of member participation, just think of the positive changes we can bring about by making our unified voice that much louder. Meaningful prior authorization reform, a viable value-based payment opportunity and sustained investment into cancer research are all possible, but they rely on your action.

Engaging your representatives and senators on these issues is easier than ever, and I encourage you to take advantage of every opportunity to support our policy goals. Write letters, send emails and engage leaders on social media. And if COVID-19 trends continue to improve in your community, please consider inviting them to visit your treatment facilities.

So, keep an eye out for those action alerts and ASTROgram stories, and be sure to check astro.org/advocate regularly. Every effort you make is another step toward improvements for our patients and our community.

Posted: April 20, 2021 | with 0 comments
Filed under: Advocacy


Comments
Blog post currently doesn't have any comments.
 Security code